Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.
Adrenal Glands
/ blood supply
Aldosterone
/ analysis
Blood Specimen Collection
/ methods
Endocrinology
/ methods
Female
Hematologic Tests
/ methods
Humans
Hyperaldosteronism
/ blood
Hypertension
/ epidemiology
Japan
/ epidemiology
Male
Middle Aged
Procedures and Techniques Utilization
/ trends
Registries
/ statistics & numerical data
Veins
Journal
Journal of human hypertension
ISSN: 1476-5527
Titre abrégé: J Hum Hypertens
Pays: England
ID NLM: 8811625
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
18
08
2018
accepted:
28
06
2019
revised:
16
06
2019
pubmed:
30
8
2019
medline:
29
5
2021
entrez:
30
8
2019
Statut:
ppublish
Résumé
Primary aldosteronism (PA) is a common curable cause of hypertension. Adrenal venous sampling (AVS) is recommended for subtype diagnosis but is a difficult procedure. Recently, an increased prevalence of PA was reported, creating a greater demand for treatment of the condition in clinical facilities. The aim of the present study was to identify the historical changes over time and the differences between facilities in the success rate and subtype diagnosis of PA. The database of the PA registry developed by the Japan PA Study (JPAS) was used. A total of 2599 patients with PA who underwent AVS were evaluated. The overall success rate of AVS was 88%. The bilateral subtype was the dominant subtype, comprising 69% of cases. During the period 2004-2011 to 2011-2017, there were significant changes in the total number of AVS procedures (from 562 to 1732), ratio of ACTH administration with AVS (75 to 97%), success rate (79 to 90%), and proportion with bilateral subtype diagnosis (53 to 72%). There were also significant inter-facility differences in the number of AVS procedures (6 to 322), success rate (59 to 97%), and proportion with the bilateral subtype (44 to 86%). The principal enrolled department was Endocrinology (86%), and the ratio of unilateral PA was significantly higher in this department than in others (32% vs. 25%). In conclusion, the number of AVS procedures performed, the success rate, and the proportion with the bilateral subtype increased over time after normalizing the centre difference. Significant differences were observed between the centres.
Identifiants
pubmed: 31462725
doi: 10.1038/s41371-019-0229-4
pii: 10.1038/s41371-019-0229-4
doi:
Substances chimiques
Aldosterone
4964P6T9RB
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
34-42Investigateurs
Masanobu Yamada
(M)
Hiromi Rakugi
(H)
Takashi Kawamura
(T)
Osamu Ogawa
(O)
Akiyo Tanabe
(A)
Tomonobu Hasegawa
(T)
Masanori Abe
(M)
Ryuichi Sakamoto
(R)
Takuro Shinbo
(T)
Tatsuya Kai
(T)
Tomikazu Fukuoka
(T)
Masanori Murakami
(M)
Shigeatsu Hashimoto
(S)
Makito Tanabe
(M)
Mitsuhiro Kometani
(M)
Yuichirou Yoshikawa
(Y)
Youichi Oono
(Y)
Hisashi Fukuda
(H)
Takashi Yoneda
(T)
Touru Sugiyama
(T)
Fumihiko Matsuda
(F)
Toshinari Yamasaki
(T)
Takahisa Kawaguchi
(T)
Références
Horm Metab Res. 2012 Mar;44(3):157-62
pubmed: 22135219
J Hum Hypertens. 2017 Dec;32(1):12-19
pubmed: 29176594
Clin Endocrinol (Oxf). 2009 Jan;70(1):14-7
pubmed: 19128364
Hypertension. 2014 Jan;63(1):151-60
pubmed: 24218436
Hypertens Res. 2006 Nov;29(11):883-9
pubmed: 17345788
Nephrol Dial Transplant. 2004 Apr;19(4):774-7
pubmed: 15031328
Endocrinology. 2003 Jun;144(6):2208-13
pubmed: 12746276
J Am Coll Cardiol. 2005 Apr 19;45(8):1243-8
pubmed: 15837256
J Clin Endocrinol Metab. 2004 Mar;89(3):1045-50
pubmed: 15001583
J Clin Endocrinol Metab. 2018 Mar 1;103(3):900-908
pubmed: 29092077
Hypertension. 2013 Aug;62(2):331-6
pubmed: 23753408
J Clin Endocrinol Metab. 2016 Jul;101(7):2826-35
pubmed: 27172433
Endocr J. 2007 Aug;54(4):487-95
pubmed: 17124364
Clin Endocrinol (Oxf). 2015 Oct;83(4):462-7
pubmed: 25727719
Arch Surg. 1996 Jun;131(6):646-50
pubmed: 8645073
Hypertension. 2012 Apr;59(4):840-6
pubmed: 22331382
J Hypertens. 2001 Mar;19(3):353-61
pubmed: 11288803
J Am Coll Cardiol. 2017 Apr 11;69(14):1811-1820
pubmed: 28385310
Surgery. 2004 Dec;136(6):1227-35
pubmed: 15657580
J Am Coll Cardiol. 2006 Dec 5;48(11):2293-300
pubmed: 17161262
Hypertens Res. 2014 Apr;37(4):253-390
pubmed: 24705419
J Clin Endocrinol Metab. 2008 Sep;93(9):3266-81
pubmed: 18552288
J Clin Endocrinol Metab. 2012 May;97(5):1606-14
pubmed: 22399502
Arch Intern Med. 2008 Jan 14;168(1):80-5
pubmed: 18195199
Endocr J. 2011;58(9):711-21
pubmed: 21828936
Clin Exp Pharmacol Physiol. 1994 Apr;21(4):315-8
pubmed: 7923898
Hypertension. 2016 May;67(5):1014-9
pubmed: 26975712
Clin Endocrinol (Oxf). 2015 Dec;83(6):768-73
pubmed: 26123796
J Clin Endocrinol Metab. 2010 Mar;95(3):1360-4
pubmed: 20089615